GENPHARMASEC Financial Statement Analysis
|
||
|
The Revenues of GENPHARMASEC have increased by 19.16% YoY .
The Earnings Per Share (EPS) of GENPHARMASEC has decreased by -100.00 % YoY. |
||
| REVENUES |
| OPERATING MARGIN |
| PROFIT AFTER TAX |
| EPS |
| ROCE |
GENPHARMASEC Last 5 Annual Financial Results
[BOM: 531592]
| Consolidated | Mar2024 | Mar2023 |
|---|---|---|
| Revenues | ₹30 Cr | ₹26 Cr |
| Expenses | ₹30 Cr | ₹25 Cr |
| Operating Profit (Excl OI) | ₹0.05 Cr | ₹0.26 Cr |
| Other Income | ₹0.66 Cr | ₹0.10 Cr |
| Interest | ₹0.41 Cr | ₹0.06 Cr |
| Depreciation | ₹0.04 Cr | ₹0.02 Cr |
| Profit Before Tax | ₹0.25 Cr | ₹0.28 Cr |
| Profit After Tax | ₹-0.17 Cr | ₹1.13 Cr |
| Consolidated Net Profit | ₹-0.13 Cr | ₹1.13 Cr |
| Earnings Per Share (Rs) | ₹0.00 | ₹0.04 |
| PAT Margin (%) | -0.56 | 4.41 |
| ROE(%) | -0.42 | 7.34 |
| ROCE(%) | 1.53 | 1.83 |
| Total Debt/Equity(x) | 0.05 | 0.20 |
Key Financials |
||
| Market Cap | : | ₹ 111.8 Cr |
| Revenue (TTM) | : | ₹ 29.9 Cr |
| Net Profit(TTM) | : | ₹ 1.5 Cr |
| EPS (TTM) | : | ₹ 0.0 |
| P/E (TTM) | : | 74.4 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| GENPHARMASEC | -0.5% | 3.1% | -7.4% |
| SUDARSHAN CHEMICAL INDUSTRIES | -1.7% | 2.1% | 41.5% |
| KIRI INDUSTRIES | -1.2% | -4.5% | 64.4% |
| VIDHI SPECIALTY FOOD INGREDIENTS | -3.1% | -7.3% | -8.1% |
| SHREE PUSHKAR CHEMICALS & FERTILISERS | 3.5% | -8.9% | 37.8% |
| BODAL CHEMICALS | 2.6% | -0.5% | -12.4% |
| BHAGERIA INDUSTRIES | -4.3% | -7.2% | -11.8% |
| DYNEMIC PRODUCTS | 0.1% | -3% | -6% |
| PODDAR PIGMENTS | -0.9% | -7.4% | -19% |
GENPHARMASEC Revenues
[BOM: 531592]
| Y-o-Y | 19.16 % |
| 5 Yr CAGR | 19.16 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2024 | ₹30 Cr | 19.16 | |
| Mar2023 | ₹26 Cr | - | |
GENPHARMASEC Operating Profit
[BOM: 531592]
| Y-o-Y | -82.10 % |
| 5 Yr CAGR | -82.10 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2024 | ₹0.05 Cr | -82.10 | |
| Mar2023 | ₹0.26 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | -85.15 % |
| 5 Yr CAGR | -85.15 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2024 | 0.15% | -85.15 | |
| Mar2023 | 1.01% | - | |
GENPHARMASEC Profit After Tax
[BOM: 531592]
| Y-o-Y | Negative |
| 5 Yr CAGR | Negative |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2024 | ₹-0.13 Cr | Negative | |
| Mar2023 | ₹1.13 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | Negative |
| 5 Yr CAGR | Negative |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2024 | -0.56 % | Negative | |
| Mar2023 | 4.41 % | - | |
GENPHARMASEC Earnings Per Share (EPS)
[BOM: 531592]
| Y-o-Y | -100.00 % |
| 5 Yr CAGR | -100.00 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2024 | ₹0.00 | -100.00 | |
| Mar2023 | ₹0.04 | - | |
GENPHARMASEC Return on Capital Employed (ROCE)
[BOM: 531592]
| Y-o-Y | -16.39 % |
| 5 Yr CAGR | -16.39 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2024 | 1.53% | -16.39 | |
| Mar2023 | 1.83% | - | |
GENPHARMASEC Share Price vs Sensex
| Current Share Price | : | ₹2.0 |
| Current MarketCap | : | ₹ 111.8 Cr |
| Updated EOD on | : | May 08,2025 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GENPHARMASEC | -0.5% |
3.1% |
-7.4% |
| SENSEX | 0.1% |
4.9% |
7.7% |
GENPHARMASEC related INDICES
No BSE index found!
No NSE index found
You may also like the below Video Courses
FAQ about GENPHARMASEC Financials
How the annual revenues of GENPHARMASEC have changed ?
The Revenues of GENPHARMASEC have increased by 19.16% YoY .
How the Earnings per Share (EPS) of GENPHARMASEC have changed?
The Earnings Per Share (EPS) of GENPHARMASEC has decreased by -100.00 % YoY .
Check out Intrinsic Value of Peers of GENPHARMASEC
Compare Stock Analytics of Peers of GENPHARMASEC
SUDARSHAN CHEMICAL INDUSTRIES LTD vs KIRI INDUSTRIES LTD vs VIDHI SPECIALTY FOOD INGREDIENTS LTD
SHREE PUSHKAR CHEMICALS & FERTILISERS LTD vs BODAL CHEMICALS LTD vs
SUDARSHAN CHEMICAL INDUSTRIES LTD vs KIRI INDUSTRIES LTD vs VIDHI SPECIALTY FOOD INGREDIENTS LTD
SHREE PUSHKAR CHEMICALS & FERTILISERS LTD vs BODAL CHEMICALS LTD vs
